In 2021, Cynthia Collins earned $1.69M in total compensation at Editas Medicine, including $86.54K salary and $1.03M in stock. Led Editas Medicine as CEO for 1 years.
Compensation History
Annual executive compensation data for Cynthia Collins, including salary, bonuses, and stock awards.
Year
2021
Total Compensation
$1.69M
Salary
$86.54K
Bonus
$0.00
Other
$575.89K
Salary
$86.54KBoard Justification
The compensation philosophy aims to attract and retain top talent while aligning executive compensation with company performance and stockholder interests.
Bonus
$0.00Board Justification
Cynthia Collins was not eligible to receive a 2021 annual performance-based cash bonus due to her separation from the company in February 2021.
Other Compensation
$575.89KBoard Justification
This includes severance payments and housing expenses as part of her separation agreement.
Restricted Stock
Board Justification
The stock awards that vested in 2021 include shares from previous grants that became fully vested upon her separation from the company.
Performance Metrics
The performance metrics for determining compensation are based on corporate goals and individual contributions, but Cynthia Collins did not receive a bonus due to her separation.
Cynthia Collins
Ex-CEO of Editas Medicine
Education
BS in Microbiology from the University of Illinois, Urbana; MBA from The University of Chicago Booth School of Business.
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
Born
January 1, 1961 - 64 years ago
CEO of Editas Medicine for
1 year 11 months (Mar 2019 - Feb 2021)
Previous Experience
CEO of Human Longevity, Inc.; CEO, IVD, of Clarient Diagnostics, Inc.; CEO and director of GenVec, Inc.; Group Vice President, Cellular Analysis of Beckman Coulter.
Other Editas Medicine CEOs
Holdings
Track Cynthia Collins's stock holdings and portfolio value over time.
Insider Trading
Cynthia Collins's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Cynthia Collins with competitor CEOs and industry peers.